Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jacobson, Amanda ^a   Bell, Frank ^a,b,c   Lejarcegui, Nicholas ^a   Mitchell, Caroline ^c,d   Frenkel, Lisa ^b,c   Horton, Helen ^a,c  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CELL SURFACE MARKER; GAMMA INTERFERON; GRANZYME B; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PROTEIN SIGLEC 7; RANTES; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; UNCLASSIFIED DRUG; CHEMOKINE; CYTOKINE; DIFFERENTIATION ANTIGEN; GRANZYME; LECTIN; NCR1 PROTEIN, HUMAN; NCR3 PROTEIN, HUMAN; SIGLEC7 PROTEIN, HUMAN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD56+ NATURAL KILLER CELL; CD56- NATURAL KILLER CELL; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; VIREMIA; VIRUS CELL INTERACTION; VIRUS INHIBITION; AUTOTRANSPLANTATION; CD4+ T LYMPHOCYTE; CYTOLOGY; FETUS BLOOD; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY; IMMUNOLOGY; METABOLISM; PHENOTYPE; PHYSIOLOGY; TRANSPLANTATION; VIRUS REPLICATION;

ADULT; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINES; FETAL BLOOD; GRANZYMES; HIV; HIV INFECTIONS; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LECTINS; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PHENOTYPE; TRANSPLANTATION, AUTOLOGOUS; VIRUS REPLICATION;

EID: 84879257445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067700     Document Type: Article

References (49)

1. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, (2008) Functions of natural killer cells. Nat Immunol 9: 503-510.
2. Zucchini N, Crozat K, Baranek T, Robbins SH, Altfeld M, et al. (2008) Natural killer cells in immunodefense against infective agents. Expert Rev Anti Infect Ther 6: 867-885.
3. Levy O, (2007) Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379-390.
4. World Health Organization (2008) The global burden of disease: 2004 update. Available: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed 22 October 2012.
5. Spira R, Lepage P, Msellati P, Van De Perre P, Leroy V, et al. (1999) Natural history of human immunodeficiency virus type 1 infection in children: A five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics 104: e56.
6. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, et al. (1997) Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 336: 1337-1342.
7. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, et al. (2004) Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. Lancet 364: 1236-1243.
8. Verneris MR, Miller JS, (2009) The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells. Br J Haematol 147: 185-191.
9. Guilmot A, Hermann E, Braud VM, Carlier Y, Truyens C, (2011) Natural killer cell responses to infections in early life. J Innate Immun 3: 280-288.
10. Wang Y, Xu H, Zheng X, Wei H, Sun R, et al. (2007) High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol 4: 377-382.
11. Gaddy J, Broxmeyer HE, (1997) Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol 180: 132-142.
12. Dalle JH, Menezes J, Wagner E, Blagdon M, Champagne J, et al. (2005) Characterization of cord blood natural killer cells: Implications for transplantation and neonatal infections. Pediatr Res 57: 649-655.
13. Cooper MA, Fehniger TA, Caligiuri MA, (2001) The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
14. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, et al. (2005) Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106: 3366-3369.
15. Bradstock KF, Luxford C, Grimsley PG, (1993) Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens. Immunol Cell Biol 71: 535-542.
16. Gaddy J, Risdon G, Broxmeyer HE, (1995) Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interferon Cytokine Res 15: 527-536.
17. Bjorkstrom NK, Ljunggren HG, Sandberg JK, (2010) CD56 negative NK cells: Origin, function, and role in chronic viral disease. Trends Immunol 31: 401-406.
18. Gonzalez VD, Falconer K, Michaelsson J, Moll M, Reichard O, et al. (2008) Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: Reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clin Immunol 128: 46-56.
19. Gonzalez VD, Falconer K, Bjorkstrom NK, Blom KG, Weiland O, et al. (2009) Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: Correlation with outcome of pegylated IFN-alpha and ribavirin treatment. J Immunol 183: 6612-6618.
20. Zarife MA, Reis EA, Carmo TM, Lopes GB, Brandao EC, et al. (2009) Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV. J Med Virol 81: 49-59.
21. Hu PF, Hultin LE, Hultin P, Hausner MA, Hirji K, et al. (1995) Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retroviro 10: 331-340.
22. Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S, et al. (2003) Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci USA 100: 15011-15016.
23. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, et al. (2005) Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci USA 102: 2886-2891.
24. De Angelis C, Mancusi A, Ruggeri L, Capanni M, Urbani E, et al. (2011) Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. Acta Haematol 126: 13-20.
25. Lu X, Kondo Y, Takamatsu H, Ohata K, Yamazaki H, et al. (2008) CD16+ CD56- NK cells in the peripheral blood of cord blood transplant recipients: A unique subset of NK cells possibly associated with graft-versus-leukemia effect. Eur J Haematol 81: 18-25.
26. Ballan WM, Vu BA, Long BR, Loo CP, Michaelsson J, et al. (2007) Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J Immunol 179: 3362-3370.
27. Bernstein HB, Kinter AL, Jackson R, Fauci AS, (2004) Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. AIDS Res Hum Retroviruses 20: 1189-1195.
28. Hermann E, Alonso-Vega C, Berthe A, Truyens C, Flores A, et al. (2006) Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells. Pediatr Res 60: 38-43.
29. Le Garff-Tavernier M, Beziat V, Decocq J, Siguret V, Gandjbakhch F, et al. (2010) Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9: 527-535.
30. Sundstrom Y, Nilsson C, Lilja G, Karre K, Troye-Blomberg M, et al. (2007) The expression of human natural killer cell receptors in early life. Scand J Immunol 66: 335-344.
31. Brunetta E, Fogli M, Varchetta S, Bozzo L, Hudspeth KL, et al. (2009) The decreased expression of siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood 114: 3822-3830.
32. Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, et al. (2006) Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 87: 2055-2065.
33. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, et al. (1998) Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 102: 223-231.
34. Dominguez E, Madrigal JA, Layrisse Z, Cohen SB, (1998) Fetal natural killer cell function is suppressed. Immunology 94: 109-114.
35. Ahmad A, Menezes J, (1996) Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals. AIDS 10: 143-149.
36. Bonaparte MI, Barker E, (2003) Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 17: 487-494.
37. Wiesmayr S, Webber SA, Macedo C, Popescu I, Smith L, et al. (2012) Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD. Eur J Immunol 42: 541-550.
38. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, et al. (2011) Innate or adaptive immunity? the example of natural killer cells. Science 331: 44-49.
39. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA, (2004) NK cell and DC interactions. Trends Immunol 25: 47-52.
40. Degli-Esposti MA, Smyth MJ, (2005) Close encounters of different kinds: Dendritic cells and NK cells take centre stage. Nat Rev Immunol 5: 112-124.
41. Moretta L, Ferlazzo G, Bottino C, Vitale M, Pende D, et al. (2006) Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214: 219-228.
42. Tasca S, Tambussi G, Nozza S, Capiluppi B, Zocchi MR, et al. (2003) Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. AIDS 17: 2291-2298.
43. Alter G, Altfeld M, (2011) Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection. Trends Immunol 32: 219-224.
44. Liu E, Tu W, Law HK, Lau YL, (2001) Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol 113: 240-246.
45. Zaghouani H, Hoeman CM, Adkins B, (2009) Neonatal immunity: Faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 30: 585-591.
46. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, et al. (2006) Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 203: 2339-2350.
47. Guia S, Cognet C, de Beaucoudrey L, Tessmer MS, Jouanguy E, et al. (2008) A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood 111: 5008-5016.
48. Smed-Sorensen A, Lore K, Walther-Jallow L, Andersson J, Spetz AL, (2004) HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104: 2810-2817.
49. Della Chiesa M, Falco M, Podestà M, Locatelli F, Moretta L, et al. (2012) Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 119: 399-410.